Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Over-allotment facility

27 Jun 2018 07:00

RNS Number : 6677S
Amati AIM VCT PLC
27 June 2018
 

 

Amati AIM VCT plc

Legal Entity Identifier: 213800HAEDBBK9RWCD25

 

Amati AIM VCT plc (the "Company")

Further to the announcement on 15 May 2018, the Company is pleased to announce that it has since made three qualifying investments and has also identified a number of new investment opportunities. The Company has therefore resolved to raise further funds by utilising the full over-allotment facility of £10m as provided for under the Terms and Conditions of the Offers.

Accordingly the offer period will be extended and the Offers will now be expected to close no later than 26 October 2018 (unless fully subscribed by an earlier date or previously closed). Application forms will be available shortly at the website of Amati Global Investors: www.amatiglobal.com.

The Company expects that the allotments in respect of the above will be made in September and October 2018.

Terms defined in the joint prospectus issued by Amati VCT plc and Amati VCT 2 plc in October 2017 have the same meaning in this announcement.

The Board of the Company does not consider this announcement to contain market sensitive information. 

For further information please contact Rachel le Derf on 0131 503 9104 or email info@amatiglobal.com

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURFFMFTMBBTBTP
Date   Source Headline
30th Nov 20209:52 amRNSNet Asset Value(s)
23rd Nov 20209:08 amRNSNet Asset Value(s)
19th Nov 20204:35 pmRNSTransaction in Own Shares
16th Nov 20202:03 pmRNSNet Asset Value(s)
9th Nov 20209:06 amRNSNet Asset Value(s)
2nd Nov 20204:47 pmRNSHolding(s) in Company
2nd Nov 20204:26 pmRNSNet Asset Value(s)
2nd Nov 20209:07 amRNSTotal Voting Rights
28th Oct 20203:07 pmRNSTransaction in Own Shares
27th Oct 20203:38 pmRNSIssue of Equity
23rd Oct 20204:18 pmRNSNet Asset Value(s)
20th Oct 20204:30 pmRNSIssue of Equity
16th Oct 20204:13 pmRNSNet Asset Value(s)
13th Oct 20202:11 pmRNSTransaction in Own Shares
13th Oct 202010:27 amRNSDirector/PDMR Shareholding
13th Oct 202010:02 amRNSIssue of Equity
12th Oct 20209:06 amRNSNet Asset Value(s)
5th Oct 20203:33 pmRNSDividend Declaration
5th Oct 20203:10 pmRNSHalf-year Report
2nd Oct 20203:52 pmRNSDirector/PDMR Shareholding
2nd Oct 20203:47 pmRNSIssue of Equity
1st Oct 20204:36 pmRNSNet Asset Value(s)
1st Oct 20202:28 pmRNSHolding(s) in Company
1st Oct 20209:34 amRNSTotal Voting Rights
25th Sep 20205:00 pmRNSNet Asset Value(s)
23rd Sep 20209:15 amRNSTransaction in Own Shares
21st Sep 20203:31 pmRNSIssue of Equity
21st Sep 20209:07 amRNSTransaction in Own Shares
21st Sep 20209:05 amRNSNet Asset Value(s)
15th Sep 20209:54 amRNSIssue of Equity
11th Sep 20204:28 pmRNSNet Asset Value(s)
8th Sep 20204:18 pmRNSTransaction in Own Shares
7th Sep 20203:01 pmRNSNet Asset Value(s)
2nd Sep 20204:56 pmRNSDirector/PDMR Shareholding
2nd Sep 20204:55 pmRNSIssue of Equity
2nd Sep 20209:36 amRNSNet Asset Value(s)
1st Sep 202012:27 pmRNSTotal Voting Rights
25th Aug 20201:58 pmRNSUpdate on offer for subscription
21st Aug 20204:50 pmRNSNet Asset Value(s)
18th Aug 20202:50 pmRNSTransaction in Own Shares
17th Aug 202011:12 amRNSNet Asset Value(s)
14th Aug 20203:08 pmRNSTransaction in Own Shares
14th Aug 20202:36 pmRNSUpdate on offer for subscription
10th Aug 202011:49 amRNSNet Asset Value(s)
5th Aug 20203:21 pmRNSTransaction in Own Shares
4th Aug 20209:53 amRNSTotal Voting Rights
4th Aug 20208:41 amRNSNet Asset Value(s)
30th Jul 20203:15 pmRNSTransaction in Own Shares
27th Jul 20209:53 amRNSDirector/PDMR Shareholding
27th Jul 20209:43 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.